Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.

Frontiers in Endocrinology（2022）

引用 0|浏览2

暂无评分

摘要

[This corrects the article DOI: 10.3389/fendo.2021.662865.].

查看译文

关键词

clinical trial,cortisol,Cushing syndrome,glucocorticoid,hypercortisolism,hyperglycemia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要